Erika Resetkova

3.1k total citations
86 papers, 2.0k citations indexed

About

Erika Resetkova is a scholar working on Pathology and Forensic Medicine, Cancer Research and Surgery. According to data from OpenAlex, Erika Resetkova has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 25 papers in Cancer Research and 23 papers in Surgery. Recurrent topics in Erika Resetkova's work include Breast Lesions and Carcinomas (26 papers), Cancer and Skin Lesions (20 papers) and Breast Cancer Treatment Studies (19 papers). Erika Resetkova is often cited by papers focused on Breast Lesions and Carcinomas (26 papers), Cancer and Skin Lesions (20 papers) and Breast Cancer Treatment Studies (19 papers). Erika Resetkova collaborates with scholars based in United States, Canada and China. Erika Resetkova's co-authors include Constance T. Albarracin, Wei Yang, Lei Huo, Nour Sneige, Shaheenah Dawood, Massimo Cristofanilli, Robert J. Volpe, Selin Çarkaci, Huong T. Le‐Petross and Homer A. Macapinlac and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Clinical Cancer Research.

In The Last Decade

Erika Resetkova

83 papers receiving 2.0k citations

Peers

Erika Resetkova
Yunn‐Yi Chen United States
Hannah Y. Wen United States
Rie Horii Japan
Silvana Di Palma United Kingdom
S Pinder United Kingdom
Zsolt Hodi United Kingdom
Yunn‐Yi Chen United States
Erika Resetkova
Citations per year, relative to Erika Resetkova Erika Resetkova (= 1×) peers Yunn‐Yi Chen

Countries citing papers authored by Erika Resetkova

Since Specialization
Citations

This map shows the geographic impact of Erika Resetkova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Resetkova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Resetkova more than expected).

Fields of papers citing papers by Erika Resetkova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Resetkova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Resetkova. The network helps show where Erika Resetkova may publish in the future.

Co-authorship network of co-authors of Erika Resetkova

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Resetkova. A scholar is included among the top collaborators of Erika Resetkova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Resetkova. Erika Resetkova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jing, Hongxia Sun, Phyu P. Aung, et al.. (2023). TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation. Archives of Pathology & Laboratory Medicine. 148(2). 200–205. 9 indexed citations
2.
Shen, Tiansheng, Jun Zhao, Min Zhao, et al.. (2022). Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfall. Human Pathology. 125. 35–47. 6 indexed citations
3.
Huang, Xiao, Qingqing Ding, Hua Guo, et al.. (2020). Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma. Human Pathology. 108. 42–50. 25 indexed citations
4.
Moseley, Tanya W., Sejal Shah, Erika Resetkova, et al.. (2019). Clinical Management of Mucocele-Like Lesions of the Breast with Limited or no Epithelial Atypia on Core Biopsy: Experience from Two Institutions. Annals of Surgical Oncology. 26(11). 3478–3488. 7 indexed citations
5.
Wang, Sumei, Do‐Youn Oh, Vasiliki Leventaki, et al.. (2019). MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer. Cancer Letters. 465. 12–23. 26 indexed citations
6.
Biazús, Jorge Villanova, et al.. (2015). Histopathological grading of breast ductal carcinoma In Situ: validation of a web-based survey through intra-observer reproducibility analysis. Diagnostic Pathology. 10(1). 93–93. 18 indexed citations
8.
Tang, Feng, Bing Wei, Zhen Tian, et al.. (2011). Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology. 59(1). 106–115. 50 indexed citations
9.
Albarracin, Constance T., Mary E. Edgerton, Michael Z. Gilcrease, et al.. (2010). Is it too soon to start reporting HER2 genetic heterogeneity?. Archives of Pathology & Laboratory Medicine. 134(2). 162–3; author reply 163. 7 indexed citations
10.
Çarkaci, Selin, Homer A. Macapinlac, Massimo Cristofanilli, et al.. (2009). Retrospective Study of 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data. Journal of Nuclear Medicine. 50(2). 231–238. 71 indexed citations
11.
Yang, Wei, Huong T. Le‐Petross, Homer A. Macapinlac, et al.. (2007). Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Research and Treatment. 109(3). 417–426. 217 indexed citations
12.
Deavers, Michael T., et al.. (2007). Giant cell tumor of soft tissue arising in breast. Annals of Diagnostic Pathology. 11(5). 345–349. 23 indexed citations
13.
Resetkova, Erika, Constance T. Albarracin, & Nour Sneige. (2006). Collagenous Spherulosis of Breast. The American Journal of Surgical Pathology. 30(1). 20–27. 32 indexed citations
15.
Resetkova, Erika, Ana M. Gonzalez‐Angulo, Nour Sneige, et al.. (2004). Prognostic value of P53, MDM‐2, and MUC‐1 for patients with inflammatory breast carcinoma. Cancer. 101(5). 913–917. 18 indexed citations
17.
YOSHIKAWA, NORIO, Guillermo Arreaza, T. Morita, et al.. (1994). Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.. The Journal of Clinical Endocrinology & Metabolism. 78(2). 367–374. 19 indexed citations
18.
YOSHIKAWA, NORIO, Guillermo Arreaza, Toshio Mukuta, et al.. (1994). Studies of Human Thyroid Xenografts from Hashimoto's Thyroiditis in Severe Combined Immunodeficient (SCID) Mice: Detection of Thyroid Stimulation-Blocking Antibody. Thyroid. 4(1). 13–18. 1 indexed citations
19.
YOSHIKAWA, NORIO, et al.. (1993). Reduced activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease. Journal of Endocrinological Investigation. 16(8). 609–617. 14 indexed citations
20.
Štrbák, V., L’Houcine Ouafik, Erika Resetkova, et al.. (1989). Thyrotropin releasing hormone in the pancreas of newborn rats from streptozotocin — Treated mothers. Life Sciences. 44(12). 779–787. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026